These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37929987)

  • 1. Reconstruction of the Blood-Brain Barrier In Vitro to Model and Therapeutically Target Neurological Disease.
    Goldman C; Suhy N; Schwarz JE; Sartori ER; Rooklin RB; Schuldt BR; Mesentier-Louro LA; Blanchard JW
    J Vis Exp; 2023 Oct; (200):. PubMed ID: 37929987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling the Blood-Brain Barrier Using Human-Induced Pluripotent Stem Cells.
    Mesentier-Louro LA; Suhy N; Broekaart D; Bula M; Pereira AC; Blanchard JW
    Methods Mol Biol; 2023; 2683():135-151. PubMed ID: 37300772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer's Disease.
    Yamazaki Y; Kanekiyo T
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28902142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial Mitochondrial Dysfunction in Cerebral Amyloid Angiopathy and Alzheimer's Disease.
    Parodi-Rullán R; Sone JY; Fossati S
    J Alzheimers Dis; 2019; 72(4):1019-1039. PubMed ID: 31306129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysfunction of the blood-brain barrier in Alzheimer's disease: Evidence from human studies.
    Kurz C; Walker L; Rauchmann BS; Perneczky R
    Neuropathol Appl Neurobiol; 2022 Apr; 48(3):e12782. PubMed ID: 34823269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pericytes in Alzheimer's Disease: Novel Clues to Cerebral Amyloid Angiopathy Pathogenesis.
    Salmina AB; Komleva YK; Lopatina OL; Birbrair A
    Adv Exp Med Biol; 2019; 1147():147-166. PubMed ID: 31147877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Traffic jam at the blood-brain barrier promotes greater accumulation of Alzheimer's disease amyloid-β proteins in the cerebral vasculature.
    Agyare EK; Leonard SR; Curran GL; Yu CC; Lowe VJ; Paravastu AK; Poduslo JF; Kandimalla KK
    Mol Pharm; 2013 May; 10(5):1557-65. PubMed ID: 23249146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reconstruction of the human blood-brain barrier in vitro reveals a pathogenic mechanism of APOE4 in pericytes.
    Blanchard JW; Bula M; Davila-Velderrain J; Akay LA; Zhu L; Frank A; Victor MB; Bonner JM; Mathys H; Lin YT; Ko T; Bennett DA; Cam HP; Kellis M; Tsai LH
    Nat Med; 2020 Jun; 26(6):952-963. PubMed ID: 32514169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ABCG2 is upregulated in Alzheimer's brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood-brain barrier for Abeta(1-40) peptides.
    Xiong H; Callaghan D; Jones A; Bai J; Rasquinha I; Smith C; Pei K; Walker D; Lue LF; Stanimirovic D; Zhang W
    J Neurosci; 2009 Apr; 29(17):5463-75. PubMed ID: 19403814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's amyloid β heterogeneous species differentially affect brain endothelial cell viability, blood-brain barrier integrity, and angiogenesis.
    Parodi-Rullán R; Ghiso J; Cabrera E; Rostagno A; Fossati S
    Aging Cell; 2020 Nov; 19(11):e13258. PubMed ID: 33155752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent progress and new challenges in modeling of human pluripotent stem cell-derived blood-brain barrier.
    Yan L; Moriarty RA; Stroka KM
    Theranostics; 2021; 11(20):10148-10170. PubMed ID: 34815809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood-Brain Barrier Disruption Increases Amyloid-Related Pathology in TgSwDI Mice.
    Abdallah IM; Al-Shami KM; Yang E; Kaddoumi A
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of cerebral amyloid angiopathy on integrity of the blood-brain barrier.
    Magaki S; Tang Z; Tung S; Williams CK; Lo D; Yong WH; Khanlou N; Vinters HV
    Neurobiol Aging; 2018 Oct; 70():70-77. PubMed ID: 30007166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro blood-brain barrier models for drug screening and permeation studies: an overview.
    Bagchi S; Chhibber T; Lahooti B; Verma A; Borse V; Jayant RD
    Drug Des Devel Ther; 2019; 13():3591-3605. PubMed ID: 31695329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel dynamic multicellular co-culture system for studying individual blood-brain barrier cell types in brain diseases and cytotoxicity testing.
    Miranda-Azpiazu P; Panagiotou S; Jose G; Saha S
    Sci Rep; 2018 Jun; 8(1):8784. PubMed ID: 29884831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNF-α and IL-1β Modulate Blood-Brain Barrier Permeability and Decrease Amyloid-β Peptide Efflux in a Human Blood-Brain Barrier Model.
    Versele R; Sevin E; Gosselet F; Fenart L; Candela P
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral Amyloid Angiopathy and Blood-Brain Barrier Dysfunction.
    Gireud-Goss M; Mack AF; McCullough LD; Urayama A
    Neuroscientist; 2021 Dec; 27(6):668-684. PubMed ID: 33238806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An In Vitro Model of the Blood-Brain Barrier to Study Alzheimer's Disease: The Role of β-Amyloid and Its Influence on PBMC Infiltration.
    Spampinato SF; Takeshita Y; Obermeier B
    Methods Mol Biol; 2022; 2492():333-352. PubMed ID: 35733055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mediators of cerebral hypoperfusion and blood-brain barrier leakiness in Alzheimer's disease, vascular dementia and mixed dementia.
    Tayler H; Miners JS; Güzel Ö; MacLachlan R; Love S
    Brain Pathol; 2021 Jul; 31(4):e12935. PubMed ID: 33410232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.
    Bell RD; Zlokovic BV
    Acta Neuropathol; 2009 Jul; 118(1):103-13. PubMed ID: 19319544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.